60
Participants
Start Date
August 31, 2015
Primary Completion Date
August 31, 2016
Study Completion Date
October 31, 2016
SANGUINATE
Two (2) infusions of 320 mg/kg of SANGUINATE at Baseline and Day 1
Normal Saline
Two (2) infusions of Normal Saline at an equal volume to SANGUINATE at Baseline and Day 1.
University of Pittsburg Medical Center, Pittsburgh
Central Pennsylvania Transplant Foundation, Harrisburg
Medstar Georgetown University Hosiptal, Washington D.C.
Medical University of South Carolina, Charleston
Augusta University, Augusta
Tampa General Hospital, Tampa
University of Toledo, Toledo
The Cleveland Clinic, Cleveland
Henry Ford Hospital, Detroit
University of Wisconsin, Madison
Northwestern University, Chicago
UIC University of Illinois at Chicago, Chicago
Ochsner Medical Center, New Orleans
Houston Methodist Hospital, Houston
Mayo Clinic Phoenix, Phoenix
University of California, Los Angeles, Los Angeles
California Institute of Renal Research, San Diego
California Pacific Medical Center, San Francisco
University of California San Francisco, San Francisco
Saint Barnabas Medical Center, Livingston
Lead Sponsor
Prolong Pharmaceuticals
INDUSTRY